Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: population-based matched cohort study

{ 'indexed': {'date-parts': [[2023, 3, 25]], 'date-time': '2023-03-25T04:57:36Z', 'timestamp': 1679720256928}, 'reference-count': 31, 'publisher': 'Springer Science and Business Media LLC', 'license': [ { 'start': { 'date-parts': [[2023, 3, 24]], 'date-time': '2023-03-24T00:00:00Z', 'timestamp': 1679616000000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}, { 'start': { 'date-parts': [[2023, 3, 24]], 'date-time': '2023-03-24T00:00:00Z', 'timestamp': 1679616000000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springernature.com/gp/researchers/text-and-data-mining'}], 'funder': [ { 'DOI': '10.13039/501100007682', 'name': 'Medicinski Fakultet, Sveučilište u Zagrebu', 'doi-asserted-by': 'publisher', 'award': ['no grant id', 'no grant id']}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'DOI': '10.1007/s00228-023-03479-3', 'type': 'journal-article', 'created': {'date-parts': [[2023, 3, 24]], 'date-time': '2023-03-24T07:02:56Z', 'timestamp': 1679641376000}, 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a ' 'reduced risk of subsequent hospitalization and death compared to their non-prescribed peers: ' 'population-based matched cohort study', 'prefix': '10.1007', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-0968-1194', 'authenticated-orcid': False, 'given': 'Vladimir', 'family': 'Trkulja', 'sequence': 'first', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-1359-3701', 'authenticated-orcid': False, 'given': 'Ivan', 'family': 'Kodvanj', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2023, 3, 24]]}, 'reference': [ { 'key': '3479_CR1', 'doi-asserted-by': 'publisher', 'first-page': '2292', 'DOI': '10.1001/jama.2020.22760', 'volume': '324', 'author': 'EJ Lenze', 'year': '2020', 'unstructured': 'Lenze EJ, Mattar C, Zorumski CF, Stevens A, Schweiger J, Nicol GE et al ' '(2020) Fluvoxamine vs placebo and clinical deterioration in outpatients ' 'with symptomatic COVID-19: a randomized clinical trial. JAMA ' '324:2292–2300', 'journal-title': 'JAMA'}, { 'key': '3479_CR2', 'doi-asserted-by': 'publisher', 'first-page': 'e42', 'DOI': '10.1016/S2214-109X(21)00448-4', 'volume': '10', 'author': 'G Reis', 'year': '2022', 'unstructured': 'Reis G, dos Santos Moreira-Silva EA, Medeiros Silva DC, Thabane L, Cruz ' 'Milagres A et al (2022) Effect of early treatment with fluvoxamine on ' 'risk of emergeny care and hospitalizations among patients with COVID-19: ' 'the TOGETHER randomized platform trial. Lancet Glob Health 10:e42-51. ' 'https://doi.org/10.1016/S2214-109X(21)00448-4', 'journal-title': 'Lancet Glob Health'}, { 'key': '3479_CR3', 'unstructured': 'Lenze E. Fluvoxamine for early treatment of COVID-19: a fully-remote, ' 'randomized placebo controlled trial. ClinicalTrials.gov.\xa0' 'https://clinicaltrials.gov/ct2/show/NCT04668950. Accessed 26 Sept 2022'}, { 'key': '3479_CR4', 'doi-asserted-by': 'publisher', 'first-page': '102', 'DOI': '10.3947/ic.2021.0142', 'volume': '54', 'author': 'H Seo', 'year': '2022', 'unstructured': 'Seo H, Kim H, Bae S, Park S, Chung H, Sung HS et al (2022) Fluvoxamine ' 'treatment of patients with symptomatic COVID-19 in a community treatment ' 'center: a preliminary result of randomized controlled trial. Infect ' 'Chemother 54:102–113', 'journal-title': 'Infect Chemother'}, { 'key': '3479_CR5', 'doi-asserted-by': 'publisher', 'first-page': '599', 'DOI': '10.1056/NEJMoa2201662', 'volume': '387', 'author': 'CT Bramante', 'year': '2022', 'unstructured': 'Bramante CT, Juling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM ' 'et al (2022) Randomized trial of metformin, ivermectin and fluvoxamine ' 'for Covid-19. N Engl J Med 387:599–610', 'journal-title': 'N Engl J Med'}, { 'key': '3479_CR6', 'doi-asserted-by': 'publisher', 'unstructured': 'McCarthy MW, Naggie S, Boulware DR, Lindsell CJ, Stewart TG, Felker GM ' 'et al (2022) Fluvoxamine for outpatient treatment of COVID-19: a ' 'decentralized, placebo-controlled, randomized platform clinical trial. ' 'medRxiv.\xa0https://doi.org/10.1101/2022.10.17.22281178', 'DOI': '10.1101/2022.10.17.22281178'}, { 'key': '3479_CR7', 'doi-asserted-by': 'publisher', 'unstructured': 'Sukhatme VP, Reiersen AM, Vayttaden SJ, Sukhatme VV (2021) Fluvoxiamine: ' 'a review of its mechanism of action and its role in COVID-19. Frontiers ' 'Pharmacol 12:652688. https://doi.org/10.3389/fphar.2021.652688', 'DOI': '10.3389/fphar.2021.652688'}, { 'key': '3479_CR8', 'doi-asserted-by': 'publisher', 'first-page': '108', 'DOI': '10.1016/j.jad.2022.03.059', 'volume': '307', 'author': 'W Zheng', 'year': '2022', 'unstructured': 'Zheng W, Sun HL, Cai H, Zhang Q, Ng CH, Xiang YT (2022) Antidepressants ' 'for COVID-19: a systematic review. J Affective Disord 307:108–114', 'journal-title': 'J Affective Disord'}, { 'key': '3479_CR9', 'doi-asserted-by': 'publisher', 'first-page': '4038', 'DOI': '10.3390/jcm11144038', 'volume': '11', 'author': 'M Mas', 'year': '2022', 'unstructured': 'Mas M, Garcia-Vincente JA, Estrada-Gelnoch A, Perez-Mana C, Papaseit E, ' 'Torrens M et al (2022) Antidepressant drugs and COVID-19: a review of ' 'basic and clinical evidence. J Clin Med 11:4038. ' 'https://doi.org/10.3390/jcm11144038', 'journal-title': 'J Clin Med'}, { 'key': '3479_CR10', 'doi-asserted-by': 'crossref', 'unstructured': 'Strom BL (2021) Study design available for pharmacoepidemiological ' 'studies. In: Strom BL, Kimmel E, Hennessy S, eds. Textbook of ' 'pharmacoepidemiology, 3rd ed. Hoboken, NJ: Wiley-Blackwell 20–46', 'DOI': '10.1002/9781119701101'}, { 'key': '3479_CR11', 'doi-asserted-by': 'publisher', 'first-page': '797', 'DOI': '10.1016/S2215-0366(21)00232-7', 'volume': '8', 'author': 'B Vai', 'year': '2021', 'unstructured': 'Vai B, Mazza MG, Delli Colli C, Foiselle M, Allen B, Benedetti F et al ' '(2021) Mental disorders and risk of COVID-19-related mortality, ' 'hospitalization, and intensive care unit admission: a systematic review ' 'and meta-analysis. Lancet Psychiatry 8:797–812', 'journal-title': 'Lancet Psychiatry'}, { 'key': '3479_CR12', 'doi-asserted-by': 'publisher', 'first-page': '1208', 'DOI': '10.1001/jamapsychiatry.2021.2274', 'volume': '78', 'author': 'G Fond', 'year': '2021', 'unstructured': 'Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW et al ' '(2021) Association between mental health disorders and mortality among ' 'patients with COVID-19 in 7 countries: a systematic review and ' 'meta-analysis. JAMA Psychiat 78:1208–1217', 'journal-title': 'JAMA Psychiat'}, { 'issue': '1', 'key': '3479_CR13', 'doi-asserted-by': 'publisher', 'first-page': '5749', 'DOI': '10.1038/s41467-020-19478-2', 'volume': '11', 'author': 'GJ Griffith', 'year': '2020', 'unstructured': 'Griffith GJ, Morris TT, Tudball MJ, Herbert A, Mancano G, Pike L et al ' '(2020) Collider bias undermines our understanding of COVID-19 disease ' 'risk and severity. Nat Commun 11(1):5749. ' 'https://doi.org/10.1038/s41467-020-19478-2', 'journal-title': 'Nat Commun'}, { 'key': '3479_CR14', 'doi-asserted-by': 'publisher', 'first-page': '1079', 'DOI': '10.1001/jamapsychiatry.2021.1818', 'volume': '78', 'author': 'F Ceban', 'year': '2021', 'unstructured': 'Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J et al (2021) ' 'Association between mood disorders and risk of COVID-19 infection, ' 'hospitalization and death. A systematic review and meta-analysis. JAMA ' 'Psychiat 78:1079–1091', 'journal-title': 'JAMA Psychiat'}, { 'key': '3479_CR15', 'doi-asserted-by': 'publisher', 'first-page': '3812', 'DOI': '10.3390/ijms23073812', 'volume': '23', 'author': 'M Mahdi', 'year': '2022', 'unstructured': 'Mahdi M, Herman L, Rethelyi JM, Balint L (2022) Potential role of ' 'antidepressants fluoxetine and fluvoxamine in the treatment of COVID-19. ' 'Int J Mol Sci 23:3812. https://doi.org/10.3390/ijms23073812', 'journal-title': 'Int J Mol Sci'}, { 'key': '3479_CR16', 'doi-asserted-by': 'publisher', 'unstructured': 'Oskotsky T, Marić I, Tang A, Oskotsky B, Wong RJ, Aghaeepour N et al ' '(2021) Mortality risk among patients with COVID-19 prescribed selective ' 'serotonin reuptake inhibitor antidepressants. JAMA Network Open ' '4(11):e2133090. https://doi.org/10.1001/jamanetworkopen.2021.33090', 'DOI': '10.1001/jamanetworkopen.2021.33090'}, { 'key': '3479_CR17', 'doi-asserted-by': 'publisher', 'unstructured': 'Ho DE, Imai K, King G, Stuart EA (2011) MatchIt\u202f: nonparametric ' 'preprocessing for parametric causal inference. J Stat Softw 42(8):1–28. ' 'https://doi.org/10.18637/jss.v042.i08', 'DOI': '10.18637/jss.v042.i08'}, { 'key': '3479_CR18', 'unstructured': 'R Core Team (2020) R: a language and environment for statistical ' 'computing. R Foundation for Statistical Computing, Vienna, Austria'}, { 'key': '3479_CR19', 'doi-asserted-by': 'publisher', 'first-page': '4654', 'DOI': '10.1111/bcp.15451', 'volume': '88', 'author': 'V Trkulja', 'year': '2022', 'unstructured': 'Trkulja V (2022) Fluvoxamine for COVID-19 outpatients: for the time ' 'being, we might prefer to curb our optimism. Br J Clin Pharmacol ' '88:4654–4656', 'journal-title': 'Br J Clin Pharmacol'}, { 'key': '3479_CR20', 'unstructured': 'Goodrich B, Gabry J, Ali I, Brilleman S (2022) rstanarm: Bayesian ' 'applied regression modeling via Stan. R package version 2.21.3 ' 'https://mc-stan.org/rstanarm/'}, { 'key': '3479_CR21', 'first-page': '187', 'volume': '2015', 'author': 'G Schwarzer', 'year': '2015', 'unstructured': 'Schwarzer G, Carpenter JR, Rucker G (2015) Meta-analysis with R. ' 'Springer International Publishing Switzerland 2015:187–216', 'journal-title': 'Springer International Publishing Switzerland'}, { 'key': '3479_CR22', 'doi-asserted-by': 'publisher', 'first-page': '196', 'DOI': '10.1186/s12874-019-0829-2', 'volume': '19', 'author': 'A Beliveau', 'year': '2019', 'unstructured': 'Beliveau A, Boyne DJ, Slater J, Brenner D, Arora P (2019) BUGSnet: an R ' 'package to facilitate the conduct and reporting of Bayesian network ' 'meta-analyses. Med Res Methodol 19:196. ' 'https://doi.org/10.1186/s12874-019-0829-2', 'journal-title': 'Med Res Methodology'}, { 'key': '3479_CR23', 'first-page': '285', 'volume': '3', 'author': 'G van Valkenhoef', 'year': '2012', 'unstructured': 'van Valkenhoef G, Lu G, de Brock B, Hillege H, Ades AE, Welton J (2012) ' 'Automating network meta-analysis. Res Synth. Methods 3:285–299', 'journal-title': 'Methods'}, { 'key': '3479_CR24', 'doi-asserted-by': 'publisher', 'first-page': '291', 'DOI': '10.1002/pds.1200', 'volume': '15', 'author': 'S Schneeweiss', 'year': '2006', 'unstructured': 'Schneeweiss S (2006) Sensitivity analysis and external adjustment for ' 'unmeasured confounders in epidemiologic database studies of ' 'therapeutics. Pharmacoepidemiol Drug Saf 15:291–303', 'journal-title': 'Pharmacoepidemiol Drug Saf'}, { 'key': '3479_CR25', 'doi-asserted-by': 'publisher', 'unstructured': 'Heine D (2021) The episensr package: basic sensitivity analysis of ' 'epidemiological results. https://doi.org/10.5281/zenodo.4554553, R ' 'package version 1.1.0. https://dhaine.github.io/episensr/', 'DOI': '10.5281/zenodo.4554553'}, { 'key': '3479_CR26', 'doi-asserted-by': 'publisher', 'first-page': '975', 'DOI': '10.1586/ern.09.53', 'volume': '9', 'author': 'BT Kuran', 'year': '2010', 'unstructured': 'Kuran BT, Greer TL, Trivedi MH (2010) Strategies to enhance the ' 'therapeutic efficacy of antidepressants: targeting residual symptoms. ' 'Expert Rev Neurother 9:975–984', 'journal-title': 'Expert Rev Neurother'}, { 'key': '3479_CR27', 'doi-asserted-by': 'publisher', 'first-page': '14', 'DOI': '10.1111/j.1600-0447.2005.00676.x', 'volume': '35', 'author': 'S Ros', 'year': '2005', 'unstructured': 'Ros S, Aguera L, de la Gandara J, Rojo JE, de Pedro JM (2005) ' 'Potentiation strategies for treatment-resistant depression. Acta ' 'Psyhciatr Scand Suppl 35:14–24', 'journal-title': 'Acta Psyhciatr Scand Suppl'}, { 'issue': 'Suppl. 22', 'key': '3479_CR28', 'first-page': '29', 'volume': '60', 'author': 'JC Ballenger', 'year': '1999', 'unstructured': 'Ballenger JC (1999) Clinical guidelines for establishing remission in ' 'patients with depression and anxiety. J Clin Psyciatry 60(Suppl. ' '22):29–34', 'journal-title': 'J Clin Psyciatry'}, { 'key': '3479_CR29', 'doi-asserted-by': 'publisher', 'unstructured': 'Hadley E, Rhea S, Jones K, Li L, Sotner M, Bobashev G (2022). Enhancing ' 'the prediction of hospitalization from a COVID-19 agent-based model: a ' 'Bayesian method for model parameter estimation. PloS ONE 17(3):e0264704. ' 'https://doi.org/10.1371/journal.pone.0264704', 'DOI': '10.1371/journal.pone.0264704'}, { 'key': '3479_CR30', 'doi-asserted-by': 'publisher', 'first-page': '311', 'DOI': '10.1186/s12879-022-07262-0', 'volume': '22', 'author': 'D Herrera-Esposito', 'year': '2022', 'unstructured': 'Herrera-Esposito D, de los Campos G, (2022) Age-specific rate of severe ' 'and critical SARS-CoV-2 infections estimated with multi-country ' 'seroprevalence studies. BMC Infect Dis 22:311. ' 'https://doi.org/10.1186/s12879-022-07262-0', 'journal-title': 'BMC Infect Dis'}, { 'key': '3479_CR31', 'unstructured': 'Croatia: Coronavirus Pandemic Country Profile - Our World in Data. ' 'Accessed 20 Sept\xa02022'}], 'container-title': 'European Journal of Clinical Pharmacology', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s00228-023-03479-3.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s00228-023-03479-3/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s00228-023-03479-3.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2023, 3, 24]], 'date-time': '2023-03-24T09:03:23Z', 'timestamp': 1679648603000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s00228-023-03479-3'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2023, 3, 24]]}, 'references-count': 31, 'alternative-id': ['3479'], 'URL': 'http://dx.doi.org/10.1007/s00228-023-03479-3', 'relation': {}, 'ISSN': ['0031-6970', '1432-1041'], 'subject': ['Pharmacology (medical)', 'Pharmacology', 'General Medicine'], 'container-title-short': 'Eur J Clin Pharmacol', 'published': {'date-parts': [[2023, 3, 24]]}, 'assertion': [ { 'value': '5 November 2022', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '14 March 2023', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '24 March 2023', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'This study used anonymized administrative data standardly collected on routine ' 'procedures, hence ethical approval was waived by the Ethics Committee of the ' 'Zagreb University School of Medicine and Croatian Institute for Public Healthy.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Ethics approval'}}, { 'value': 'The authors declare no competing interests.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Competing interests'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}